After Divestiture, FTC To Allow Drug Acquistion
The regulator said Monday that the deal as proposed would have created a monopoly in the U.S. for generic isradipine capsules. The drug is typically prescribed to patients to lower their blood pressure, and is also used to treat hypertension, ischemia, and depression.
The companies agreed to divest all the rights and assets to make...
To view the full article, register now.